Lv1
90 积分 2025-05-23 加入
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial
2天前
已完结
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
3个月前
已完结
Efficacy and Safety of Stereotactic Body Radiotherapy Combined with Camrelizumab and Apatinib in Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
3个月前
已完结
Clinical Course of Patients With Relapsed Multiple Myeloma
3个月前
已完结
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
3个月前
已完结
Cost–Utility Analysis of Darolutamide Combined with Androgen Deprivation Therapy for Patients with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer in China
5个月前
已完结
Cost-effectiveness Analysis of Trastuzumab Emtansine as Second-line Therapy for HER2-Positive Breast Cancer in China
5个月前
已完结
Cost-Effectiveness of Donafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma in China
5个月前
已完结
Towards Real-World Adverse Weather Image Restoration: Enhancing Clearness and Semantics with Vision-Language Models
3个月前
已采纳
Integrating Waiting into the Experience: A Study on Visual Feedback Design for AI Doctor Agents
3个月前
已采纳
Daridorexant. Dual orexin OX1/OX2 receptor antagonist, Treatment of sleep disorders
3个月前
已驳回
Graphene-enhanced Polymer Composite Material in Sensor Substrate Application
3个月前
已采纳
皖公网安备34019202002308
